Healthcare Triangle Inc. has announced a regulatory issue concerning its continued listing on the Nasdaq Stock Market. The company received notices from Nasdaq indicating non-compliance with several listing rules. Initially, the company failed to meet the Minimum Bid Price Requirement, with its securities trading below $1 for 30 consecutive days. Further, Nasdaq raised public interest concerns due to substantial shareholder dilution from a private placement. Additionally, the company's securities recorded a closing bid price of $0.10 or less for ten consecutive trading days, triggering the Low Priced Stocks Rule. Healthcare Triangle Inc. has responded to the Nasdaq Hearings Panel and is exploring alternative actions to regain compliance. However, there is no assurance of meeting the necessary listing requirements.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。